ONO PHARMACEUTICAL CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,275 JPY | +3.41% |
|
+1.29% | -9.58% |
| 30/04 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
| 29/04 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
| Sales 2024 | 503B 3.2B 267B | Sales 2025 * | 471B 2.99B 249B | Capitalization | 1,068B 6.8B 567B |
|---|---|---|---|---|---|
| Net income 2024 | 128B 814M 67.85B | Net income 2025 * | 92.99B 592M 49.3B | EV / Sales 2024 | 2.29 x |
| Net cash position 2024 * | 146B 926M 77.17B | Net cash position 2025 * | 188B 1.19B 99.55B | EV / Sales 2025 * | 1.87 x |
| P/E ratio 2024 |
9.21
x | P/E ratio 2025 * |
11.3
x | Employees | 3,761 |
| Yield 2024 |
3.26% | Yield 2025 * |
3.56% | Free-Float | 75.9% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ono Pharmaceutical Co., Ltd.
More recommendations
More press releases
More news
| 1 day | +3.41% | ||
| 1 week | +1.29% | ||
| 1 month | -1.32% | ||
| 3 months | -8.54% | ||
| 6 months | -15.99% | ||
| Current year | -9.58% |
1 week
2 191.50
2 275.00
1 month
2 153.502 391.00
Current year
2 153.502 777.00
1 year
2 153.502 966.50
3 years
2 153.503 990.00
5 years
1 841.003 990.00
10 years
1 542.005 880.00
| Managers | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 65 | 01/83/01 |
Toichi Takino
PSD | President | 55 | - |
| Director/Board Member | 64 | 01/85/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shusaku Nagae
BRD | Director/Board Member | 74 | - |
Gyo Sagara
CEO | Chief Executive Officer | 65 | 01/83/01 |
| Director/Board Member | 64 | 01/85/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.23% | 19 M€ | +11.22% | ||
| 0.67% | 240 M€ | +17.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 2,275 | +3.41% | 9,815,700 |
| 30/24/30 | 2,200 | -0.18% | 2,176,600 |
| 29/24/29 | 2,204 | -0.18% | 1,414,100 |
| 28/24/28 | 2,208 | +0.45% | 1,730,100 |
| 27/24/27 | 2,198 | -2.14% | 2,459,900 |
Delayed Quote Japan Exchange, May 31, 2024 at 11:30 am IST
More quotes
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
29/07/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,275
JPY
Average target price
2,622
JPY
Spread / Average Target
+15.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.58% | 6.8B | |
| +15.91% | 41.97B | |
| +22.40% | 22.34B | |
| +18.48% | 15.25B | |
| +16.12% | 14B | |
| +45.12% | 12.06B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.49B | |
| +4.00% | 4.62B |
- Stock Market
- Equities
- 4528 Stock
